100
Participants
Start Date
September 1, 2024
Primary Completion Date
March 31, 2027
Study Completion Date
May 1, 2027
Immunotherapy combined with targeted therapy
Immunotherapy combined with targeted therapy
Standard treatment plan
Standard treatment plan
RECRUITING
2ndAffiliated Hospital, School of Medicine, Zhejiang University, Hangzhou
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER